These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34314916)

  • 21. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
    Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
    Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modelling and synthesis of spiroimidazolidine-2,4-diones with dual activities as hypoglycemic agents and selective inhibitors of aldose reductase.
    Salem MG; Abdel Aziz YM; Elewa M; Elshihawy HA; Said MM
    Bioorg Chem; 2018 Sep; 79():131-144. PubMed ID: 29751319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ponalrestat: a potent and specific inhibitor of aldose reductase.
    Ward WH; Sennitt CM; Ross H; Dingle A; Timms D; Mirrlees DJ; Tuffin DP
    Biochem Pharmacol; 1990 Jan; 39(2):337-46. PubMed ID: 2105733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel insights into the structural requirements for the design of selective and specific aldose reductase inhibitors.
    Kumar H; Shah A; Sobhia ME
    J Mol Model; 2012 May; 18(5):1791-9. PubMed ID: 21833829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure optimization of tetrahydropyridoindole-based aldose reductase inhibitors improved their efficacy and selectivity.
    Majekova M; Ballekova J; Prnova M; Stefek M
    Bioorg Med Chem; 2017 Dec; 25(24):6353-6360. PubMed ID: 29074349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development, Molecular Docking, and
    Imran A; Shehzad MT; Shah SJA; Laws M; Al-Adhami T; Rahman KM; Khan IA; Shafiq Z; Iqbal J
    ACS Omega; 2022 Aug; 7(30):26425-26436. PubMed ID: 35936488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids.
    Koukoulitsa C; Bailly F; Pegklidou K; Demopoulos VJ; Cotelle P
    Eur J Med Chem; 2010 Apr; 45(4):1663-6. PubMed ID: 20071057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of 2-benzoxazolinone derivatives as lead against molecular targets of diabetic complications.
    Vyas B; Choudhary S; Singh PK; Singh B; Bahadur R; Malik AK; Silakari O
    Chem Biol Drug Des; 2018 Dec; 92(6):1981-1987. PubMed ID: 30030901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket.
    Hlaváč M; Kováčiková L; Šoltésová Prnová M; Addová G; Hanquet G; Štefek M; Boháč A
    Bioorg Med Chem; 2021 Jan; 29():115885. PubMed ID: 33271452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.
    Ji Y; Chen X; Chen H; Zhang X; Fan Z; Xie L; Ma B; Zhu C
    Bioorg Med Chem; 2019 Apr; 27(8):1658-1669. PubMed ID: 30858026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substituted 2-thioxothiazolidin-4-one derivatives showed protective effects against diabetic cataract via inhibition of aldose reductase.
    Huang W; Zhang Y; Liang X; Yang L
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e1900371. PubMed ID: 32237167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK; Sundaram K; Ravi S
    Bioorg Chem; 2020 Apr; 97():103640. PubMed ID: 32086051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and structure-activity relationship studies of phenolic hydroxyl derivatives based on quinoxalinone as aldose reductase inhibitors with antioxidant activity.
    Hao X; Han Z; Li Y; Li C; Wang X; Zhang X; Yang Q; Ma B; Zhu C
    Bioorg Med Chem Lett; 2017 Feb; 27(4):887-892. PubMed ID: 28109789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldose reductase inhibitors from the nature.
    Kawanishi K; Ueda H; Moriyasu M
    Curr Med Chem; 2003 Aug; 10(15):1353-74. PubMed ID: 12871134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based optimization of aldose reductase inhibitors originating from virtual screening.
    Eisenmann M; Steuber H; Zentgraf M; Altenkämper M; Ortmann R; Perruchon J; Klebe G; Schlitzer M
    ChemMedChem; 2009 May; 4(5):809-19. PubMed ID: 19301313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-(Aroyl)-N-(arylmethyloxy)-α-alanines: Selective inhibitors of aldose reductase.
    Nencetti S; La Motta C; Rossello A; Sartini S; Nuti E; Ciccone L; Orlandini E
    Bioorg Med Chem; 2017 Jun; 25(12):3068-3076. PubMed ID: 28392277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydrobenzoxazinone derivatives as aldose reductase inhibitors with antioxidant activity.
    Chen H; Zhang X; Zhang X; Fan Z; Liu W; Lei Y; Zhu C; Ma B
    Bioorg Med Chem; 2020 Oct; 28(20):115699. PubMed ID: 33069078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1-Hydroxypyrazole as a bioisostere of the acetic acid moiety in a series of aldose reductase inhibitors.
    Papastavrou N; Chatzopoulou M; Pegklidou K; Nicolaou I
    Bioorg Med Chem; 2013 Sep; 21(17):4951-7. PubMed ID: 23891165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin K1 prevents diabetic cataract by inhibiting lens aldose reductase 2 (ALR2) activity.
    Thiagarajan R; Varsha MKNS; Srinivasan V; Ravichandran R; Saraboji K
    Sci Rep; 2019 Oct; 9(1):14684. PubMed ID: 31604989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing activity and selectivity in a series of pyrrol-1-yl-1-hydroxypyrazole-based aldose reductase inhibitors: The case of trifluoroacetylation.
    Papastavrou N; Chatzopoulou M; Ballekova J; Cappiello M; Moschini R; Balestri F; Patsilinakos A; Ragno R; Stefek M; Nicolaou I
    Eur J Med Chem; 2017 Apr; 130():328-335. PubMed ID: 28259841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.